Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome

التفاصيل البيبلوغرافية
العنوان: Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome
المؤلفون: Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata M. Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo, Alessia Tieghi, Florian H. Heidel, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Mattia Biondo, Marta Venturi, Luigi Scaffidi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M. Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Daniela Bartoletti, Simona Paglia, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Giuseppe A. Palumbo
المصدر: Cancer. 129:1704-1713
بيانات النشر: Wiley, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Cancer Research, Oncology, ruxolitinib, cytopenia, myelofibrosis, myelodepletive phenotype, myeloproliferative neoplasms
تدمد: 1097-0142
0008-543X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75234af541a1ffd87d4f63defcaf092aTest
https://doi.org/10.1002/cncr.34722Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....75234af541a1ffd87d4f63defcaf092a
قاعدة البيانات: OpenAIRE